Patents/Assignees

Secarna Pharmaceuticals GmbH & Co. KG

3 patents in portfolio

US11959083utility2024
Immunosuppression-reverting Oligonucleotides Inhibiting the Expression of CD39
0 cites
US11781136utility2023
Oligonucleotide Inhibiting the Expression of Chop
0 cites
US11666595utility2023
Antisense Oligonucleotides for Inhibition of PD-L1 Expression and Treating Cancer
0 cites